Redian新闻
>
FLML 都逃跑了吗?
avatar
FLML 都逃跑了吗?# Stock
C*X
1
新机会来了
avatar
u*n
2
能去14吗,准备等着。。
avatar
C*X
3
14开始新一轮

【在 u******n 的大作中提到】
: 能去14吗,准备等着。。
avatar
c*f
4
what happen..
avatar
u*n
5
其实去过了,miss了,老李不厚道。。
avatar
x*n
6
新一轮反弹吗?
[在 CPRX (不买高点) 的大作中提到:]
:14开始新一轮
:【 在 upendown (northensouth) 的大作中提到: 】
:...........
avatar
C*X
7
别急,等14
avatar
O*N
8
这里的人是和FLML干上了
差不多就可以撤了
avatar
x*n
9
快14啦,捞不捞?
[在 CPRX (不买高点) 的大作中提到:]
:别急,等14
avatar
l*t
10
没,哭死

【在 C**X 的大作中提到】
: 新机会来了
avatar
l*t
11
14 again, in for some? or wait for 12?
avatar
s*i
12
嗯,要去12 了,飞奔的那种。

【在 l*********t 的大作中提到】
: 14 again, in for some? or wait for 12?
avatar
l*i
13
今天为毛跌这么多?两个月的涨幅一天跌完,太狠了
avatar
O*N
14

难道有人有内幕消息?

【在 l********i 的大作中提到】
: 今天为毛跌这么多?两个月的涨幅一天跌完,太狠了
avatar
d*r
15
From Bloomberg today
FLML developing Micropump for single dose of Sodiul oxybate to traet
narcolepsy; Jazz Pharma's Xyrem uses two doses of sodium oxybate Patent
trail and appeal board yesterday issued decision denying covered business
method patent review for 4 Xyrem patents covering restricted distribution ,
JPMorgan analyst Jessica Fye said in note She sees as incremental poistive
for Jazz, removes potential threat to Xyrem franchise
是这个?

【在 l********i 的大作中提到】
: 今天为毛跌这么多?两个月的涨幅一天跌完,太狠了
avatar
l*i
16
U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
currently markets as Bloxiverz.
这是真正的消息。原来只有他们一家批准,其他的都得下市,现在竞争的来了

,

【在 d**********r 的大作中提到】
: From Bloomberg today
: FLML developing Micropump for single dose of Sodiul oxybate to traet
: narcolepsy; Jazz Pharma's Xyrem uses two doses of sodium oxybate Patent
: trail and appeal board yesterday issued decision denying covered business
: method patent review for 4 Xyrem patents covering restricted distribution ,
: JPMorgan analyst Jessica Fye said in note She sees as incremental poistive
: for Jazz, removes potential threat to Xyrem franchise
: 是这个?

avatar
d*r
17
原来如此!

【在 l********i 的大作中提到】
: U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
: Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
: currently markets as Bloxiverz.
: 这是真正的消息。原来只有他们一家批准,其他的都得下市,现在竞争的来了
:
: ,

avatar
x*9
18
谢谢。。。龙老师

U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
Drug Applicati........

【在 l********i 的大作中提到】
: U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
: Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
: currently markets as Bloxiverz.
: 这是真正的消息。原来只有他们一家批准,其他的都得下市,现在竞争的来了
:
: ,

avatar
c*f
19
soga!

【在 l********i 的大作中提到】
: U.S. Food and Drug Administration (FDA) has approved Fresenius Kabi's New
: Drug Application (NDA) for neostigmine methylsulfate, a drug which Flamel
: currently markets as Bloxiverz.
: 这是真正的消息。原来只有他们一家批准,其他的都得下市,现在竞争的来了
:
: ,

avatar
H*6
20
太晚看到帖,虧飛了。。。
avatar
N*d
21
short to death. 哈哈
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。